SFX by Ex Libris Inc.

Title:	Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1
Source:	Human Molecular Genetics [0964-6906] Zucker, Birgit yr:2004

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Benshachar, D. "SELECTIVITY OF MELANINIZED NIGRA-STRIATAL DOPAMINE NEURONS TO DEGENERATION IN PARKINSONS-DISEASE MAY DEPEND ON IRON-MELANIN INTERACTION." Journal of Neural Transmission (1990): 251-258.
description	2.	Olson, James M M. "Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease." Human Molecular Genetics 11.17 (2002): 1939-51.
description	3.	Zaloga, G P P. "Hypocalcemia in critically ill patients." Critical care medicine 20.2 (1992): 251-62.
description	4.	Kelly, A. "Hypocalcemia in the Critically Ill patient." Journal of intensive care medicine 28.3 (2011): 166-177.
description	5.	Luthi-Carter, R. "Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain." Human Molecular Genetics 11.17 (2002): 1911-26.
description	6.	Grasso, S. "Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular." Neuromuscular disorders 15.9-10 (2005): 577-587.
description	7.	Kato, T. "Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder." Cell calcium 44.1 (2008): 92-102.
description	8.	Kramer, L, L. "Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients." Critical care medicine 31.10 (2003): 2450-5.
description	9.	Bezprozvanny, I. "Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1." Neuron 39.2 (2003): 227-239.
description	10.	Luthi-Carter Ruth, R. "Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects." Human Molecular Genetics 11.17 (2002): 1927-37.
description	11.	Ryan, M J J. "Hypocalcemia: a pervasive metabolic abnormality in the critically ill." American journal of kidney diseases 37.4 (2001): 689-98.
description	12.	Finning, Kirstin M M. "Non-invasive fetal sex determination: impact on clinical practice." Seminars in fetal and neonatal medicine 13.2 (2008): 69-75.
description	13.	Lees, A J J. "Ageing and Parkinson's disease: substantia nigra regional selectivity." Brain 114.5 (1991): 2283-301.
description	14.	Dickerson, Roland N N. "Treatment of hypocalcemia in critical illness--part 1." Nutrition 23.4 (2007): 358-61.
description	15.	Bezprozvanny, I. "Deranged neuronal calcium signaling and Huntington disease." Biochemical and biophysical research communications 322.4 (2004): 1310-7.
description	16.	Morgera, S. "A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure." Nephron. Clinical practice 98.1 (2004): 35-40.
description	17.	Berk, M. "A model of the mitochondrial basis of bipolar disorder." Neuroscience & biobehavioral reviews 74.Pt A (2017): 1-20.
description	18.	Matzuk, Martin M. "Preservation of hypothalamic dopaminergic neurons in Parkinson's disease." Annals of neurology 18.5 (1985): 552-555.
description	19.	Egi, M. "Ionized calcium concentration and outcome in critical illness." Critical care medicine 39.2 (2010): 314-321.
description	20.	Dickerson, Roland N N. "Treatment of moderate to severe acute hypocalcemia in critically ill trauma patients." JPEN, Journal of parenteral and enteral nutrition 31.3 (2007): 228-33.